Blume Capital Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $169 | Hold |
83
| – | – | ﹤0.01% | 419 |
|
2025
Q1 | $136 | Hold |
83
| – | – | ﹤0.01% | 444 |
|
2024
Q4 | $152 | Hold |
83
| – | – | ﹤0.01% | 319 |
|
2024
Q3 | $480 | Hold |
83
| – | – | ﹤0.01% | 343 |
|
2024
Q2 | $671 | Hold |
83
| – | – | ﹤0.01% | 304 |
|
2024
Q1 | $1.15K | Hold |
83
| – | – | ﹤0.01% | 295 |
|
2023
Q4 | $510 | Hold |
83
| – | – | ﹤0.01% | 305 |
|
2023
Q3 | $389 | Hold |
83
| – | – | ﹤0.01% | 306 |
|
2023
Q2 | $447 | Hold |
83
| – | – | ﹤0.01% | 309 |
|
2023
Q1 | $820 | Hold |
83
| – | – | ﹤0.01% | 294 |
|
2022
Q4 | $1.56K | Hold |
83
| – | – | ﹤0.01% | 295 |
|
2022
Q3 | $2K | Hold |
83
| – | – | ﹤0.01% | 293 |
|
2022
Q2 | $2K | Hold |
83
| – | – | ﹤0.01% | 295 |
|
2022
Q1 | $4K | Hold |
83
| – | – | ﹤0.01% | 293 |
|
2021
Q4 | $5K | Hold |
83
| – | – | ﹤0.01% | 277 |
|
2021
Q3 | $7K | Hold |
83
| – | – | ﹤0.01% | 268 |
|
2021
Q2 | $9K | Hold |
83
| – | – | ﹤0.01% | 245 |
|
2021
Q1 | $9K | Hold |
83
| – | – | ﹤0.01% | 225 |
|
2020
Q4 | $9K | Hold |
83
| – | – | ﹤0.01% | 191 |
|
2020
Q3 | $12K | Hold |
83
| – | – | 0.01% | 172 |
|
2020
Q2 | $27K | Hold |
83
| – | – | 0.02% | 137 |
|
2020
Q1 | $7K | Hold |
83
| – | – | ﹤0.01% | 193 |
|
2019
Q4 | $3K | Hold |
83
| – | – | ﹤0.01% | 219 |
|
2019
Q3 | $2K | Hold |
83
| – | – | ﹤0.01% | 222 |
|
2019
Q2 | $3K | Hold |
83
| – | – | ﹤0.01% | 205 |
|
2019
Q1 | $4K | Hold |
83
| – | – | ﹤0.01% | 211 |
|
2018
Q4 | $4K | Hold |
83
| – | – | ﹤0.01% | 206 |
|
2018
Q3 | $6K | Hold |
83
| – | – | ﹤0.01% | 176 |
|
2018
Q2 | $4K | Hold |
83
| – | – | ﹤0.01% | 178 |
|
2018
Q1 | $4K | Hold |
83
| – | – | ﹤0.01% | 192 |
|
2017
Q4 | $4K | Hold |
83
| – | – | ﹤0.01% | 209 |
|
2017
Q3 | $6K | Hold |
83
| – | – | ﹤0.01% | 208 |
|
2017
Q2 | $8K | Hold |
83
| – | – | ﹤0.01% | 167 |
|
2017
Q1 | $7K | Hold |
83
| – | – | ﹤0.01% | 164 |
|
2016
Q4 | $7K | Hold |
83
| – | – | ﹤0.01% | 174 |
|
2016
Q3 | $9K | Buy |
+83
| New | +$9K | 0.01% | 156 |
|